Global Biosimilars/follow-on-biologics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 178437
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Biosimilars/follow-on-biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biosimilars/follow-on-biologics size is estimated to be USD 10730 million in 2025 from USD 9560.2 million in 2019, with a change XX% between 2019 and 2020. The global Biosimilars/follow-on-biologics market size is expected to grow at a CAGR of 2.9% for the next five years.

Market segmentation

Biosimilars/follow-on-biologics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Human growth hormone

Erythropoietin

Monoclonal antibodies

Insulin

Interferon

Granulocyte-Colony Stimulating Factor

Others

Market segment by Application, can be divided into

Blood disorders

Oncology diseases

Chronic and autoimmune diseases

Growth hormone deficiencies

Others

Market segment by players, this report covers

Novartis (Sandoz)

Synthon Pharmaceuticals

Teva Pharmaceutical Industries

LG Life Sciences

Celltrion Biocon

Hospira

Merck Serono (Merck)

Biogen idec

Genentech (Roche)

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Biosimilars/follow-on-biologics

1.2 Classification of Biosimilars/follow-on-biologics by Type

1.2.1 Overview: Global Biosimilars/follow-on-biologics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Type in 2020

1.2.3 Human growth hormone

1.2.4 Erythropoietin

1.2.5 Monoclonal antibodies

1.2.6 Insulin

1.2.7 Interferon

1.2.8 Granulocyte-Colony Stimulating Factor

1.2.9 Others

1.3 Global Biosimilars/follow-on-biologics Market by Application

1.3.1 Overview: Global Biosimilars/follow-on-biologics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Blood disorders

1.3.3 Oncology diseases

1.3.4 Chronic and autoimmune diseases

1.3.5 Growth hormone deficiencies

1.3.6 Others

1.4 Global Biosimilars/follow-on-biologics Market Size & Forecast

1.5 Global Biosimilars/follow-on-biologics Market Size and Forecast by Region

1.5.1 Global Biosimilars/follow-on-biologics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Biosimilars/follow-on-biologics Market Size by Region, (2016-2021)

1.5.3 North America Biosimilars/follow-on-biologics Market Size and Prospect (2016-2026)

1.5.4 Europe Biosimilars/follow-on-biologics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Biosimilars/follow-on-biologics Market Size and Prospect (2016-2026)

1.5.6 South America Biosimilars/follow-on-biologics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Biosimilars/follow-on-biologics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Biosimilars/follow-on-biologics Market Drivers

1.6.2 Biosimilars/follow-on-biologics Market Restraints

1.6.3 Biosimilars/follow-on-biologics Trends Analysis

2 Company Profiles

2.1 Novartis (Sandoz)

2.1.1 Novartis (Sandoz) Details

2.1.2 Novartis (Sandoz) Major Business

2.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Product and Solutions

2.1.4 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Novartis (Sandoz) Recent Developments and Future Plans

2.2 Synthon Pharmaceuticals

2.2.1 Synthon Pharmaceuticals Details

2.2.2 Synthon Pharmaceuticals Major Business

2.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product and Solutions

2.2.4 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Synthon Pharmaceuticals Recent Developments and Future Plans

2.3 Teva Pharmaceutical Industries

2.3.1 Teva Pharmaceutical Industries Details

2.3.2 Teva Pharmaceutical Industries Major Business

2.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product and Solutions

2.3.4 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Teva Pharmaceutical Industries Recent Developments and Future Plans

2.4 LG Life Sciences

2.4.1 LG Life Sciences Details

2.4.2 LG Life Sciences Major Business

2.4.3 LG Life Sciences Biosimilars/follow-on-biologics Product and Solutions

2.4.4 LG Life Sciences Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 LG Life Sciences Recent Developments and Future Plans

2.5 Celltrion Biocon

2.5.1 Celltrion Biocon Details

2.5.2 Celltrion Biocon Major Business

2.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Product and Solutions

2.5.4 Celltrion Biocon Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Celltrion Biocon Recent Developments and Future Plans

2.6 Hospira

2.6.1 Hospira Details

2.6.2 Hospira Major Business

2.6.3 Hospira Biosimilars/follow-on-biologics Product and Solutions

2.6.4 Hospira Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Hospira Recent Developments and Future Plans

2.7 Merck Serono (Merck)

2.7.1 Merck Serono (Merck) Details

2.7.2 Merck Serono (Merck) Major Business

2.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Product and Solutions

2.7.4 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Merck Serono (Merck) Recent Developments and Future Plans

2.8 Biogen idec

2.8.1 Biogen idec Details

2.8.2 Biogen idec Major Business

2.8.3 Biogen idec Biosimilars/follow-on-biologics Product and Solutions

2.8.4 Biogen idec Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Biogen idec Recent Developments and Future Plans

2.9 Genentech (Roche)

2.9.1 Genentech (Roche) Details

2.9.2 Genentech (Roche) Major Business

2.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Product and Solutions

2.9.4 Genentech (Roche) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Genentech (Roche) Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Biosimilars/follow-on-biologics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Biosimilars/follow-on-biologics Players Market Share

3.2.2 Top 10 Biosimilars/follow-on-biologics Players Market Share

3.2.3 Market Competition Trend

3.3 Biosimilars/follow-on-biologics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Biosimilars/follow-on-biologics Revenue and Market Share by Type (2016-2021)

4.2 Global Biosimilars/follow-on-biologics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Biosimilars/follow-on-biologics Revenue Market Share by Application (2016-2021)

5.2 Biosimilars/follow-on-biologics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Biosimilars/follow-on-biologics Revenue by Type (2016-2026)

6.2 North America Biosimilars/follow-on-biologics Revenue by Application (2016-2026)

6.3 North America Biosimilars/follow-on-biologics Market Size by Country

6.3.1 North America Biosimilars/follow-on-biologics Revenue by Country (2016-2026)

6.3.2 United States Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

6.3.3 Canada Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

6.3.4 Mexico Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Biosimilars/follow-on-biologics Revenue by Type (2016-2026)

7.2 Europe Biosimilars/follow-on-biologics Revenue by Application (2016-2026)

7.3 Europe Biosimilars/follow-on-biologics Market Size by Country

7.3.1 Europe Biosimilars/follow-on-biologics Revenue by Country (2016-2026)

7.3.2 Germany Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

7.3.3 France Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

7.3.5 Russia Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

7.3.6 Italy Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Type (2016-2026)

8.2 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Application (2016-2026)

8.3 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region

8.3.1 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Region (2016-2026)

8.3.2 China Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

8.3.3 Japan Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

8.3.4 South Korea Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

8.3.5 India Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

8.3.7 Australia Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Biosimilars/follow-on-biologics Revenue by Type (2016-2026)

9.2 South America Biosimilars/follow-on-biologics Revenue by Application (2016-2026)

9.3 South America Biosimilars/follow-on-biologics Market Size by Country

9.3.1 South America Biosimilars/follow-on-biologics Revenue by Country (2016-2026)

9.3.2 Brazil Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

9.3.3 Argentina Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Biosimilars/follow-on-biologics Revenue by Type (2016-2026)

10.2 Middle East & Africa Biosimilars/follow-on-biologics Revenue by Application (2016-2026)

10.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country

10.3.1 Middle East & Africa Biosimilars/follow-on-biologics Revenue by Country (2016-2026)

10.3.2 Turkey Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

10.3.4 UAE Biosimilars/follow-on-biologics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Biosimilars/follow-on-biologics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Biosimilars/follow-on-biologics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Biosimilars/follow-on-biologics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Biosimilars/follow-on-biologics Revenue Market Share by Region (2021-2026)

Table 6. Novartis (Sandoz) Corporate Information, Head Office, and Major Competitors

Table 7. Novartis (Sandoz) Major Business

Table 8. Novartis (Sandoz) Biosimilars/follow-on-biologics Product and Solutions

Table 9. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Synthon Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 11. Synthon Pharmaceuticals Major Business

Table 12. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product and Solutions

Table 13. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors

Table 15. Teva Pharmaceutical Industries Major Business

Table 16. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product and Solutions

Table 17. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. LG Life Sciences Corporate Information, Head Office, and Major Competitors

Table 19. LG Life Sciences Major Business

Table 20. LG Life Sciences Biosimilars/follow-on-biologics Product and Solutions

Table 21. LG Life Sciences Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Celltrion Biocon Corporate Information, Head Office, and Major Competitors

Table 23. Celltrion Biocon Major Business

Table 24. Celltrion Biocon Biosimilars/follow-on-biologics Product and Solutions

Table 25. Celltrion Biocon Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Hospira Corporate Information, Head Office, and Major Competitors

Table 27. Hospira Major Business

Table 28. Hospira Biosimilars/follow-on-biologics Product and Solutions

Table 29. Hospira Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Merck Serono (Merck) Corporate Information, Head Office, and Major Competitors

Table 31. Merck Serono (Merck) Major Business

Table 32. Merck Serono (Merck) Biosimilars/follow-on-biologics Product and Solutions

Table 33. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Biogen idec Corporate Information, Head Office, and Major Competitors

Table 35. Biogen idec Major Business

Table 36. Biogen idec Biosimilars/follow-on-biologics Product and Solutions

Table 37. Biogen idec Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Genentech (Roche) Corporate Information, Head Office, and Major Competitors

Table 39. Genentech (Roche) Major Business

Table 40. Genentech (Roche) Biosimilars/follow-on-biologics Product and Solutions

Table 41. Genentech (Roche) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Players (2019-2021)

Table 43. Global Biosimilars/follow-on-biologics Revenue Share by Players (2019-2021)

Table 44. Breakdown of Biosimilars/follow-on-biologics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 45. Biosimilars/follow-on-biologics Players Head Office, Products and Services Provided

Table 46. Biosimilars/follow-on-biologics Mergers & Acquisitions in the Past Five Years

Table 47. Biosimilars/follow-on-biologics New Entrants and Expansion Plans

Table 48. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Type (2016-2021)

Table 49. Global Biosimilars/follow-on-biologics Revenue Share by Type (2016-2021)

Table 50. Global Biosimilars/follow-on-biologics Revenue Forecast by Type (2021-2026)

Table 51. Global Biosimilars/follow-on-biologics Revenue by Application (2016-2021)

Table 52. Global Biosimilars/follow-on-biologics Revenue Forecast by Application (2021-2026)

Table 53. North America Biosimilars/follow-on-biologics Revenue by Type (2016-2021) & (USD Million)

Table 54. North America Biosimilars/follow-on-biologics Revenue by Type (2021-2026) & (USD Million)

Table 55. North America Biosimilars/follow-on-biologics Revenue by Application (2016-2021) & (USD Million)

Table 56. North America Biosimilars/follow-on-biologics Revenue by Application (2021-2026) & (USD Million)

Table 57. North America Biosimilars/follow-on-biologics Revenue by Country (2016-2021) & (USD Million)

Table 58. North America Biosimilars/follow-on-biologics Revenue by Country (2021-2026) & (USD Million)

Table 59. Europe Biosimilars/follow-on-biologics Revenue by Type (2016-2021) & (USD Million)

Table 60. Europe Biosimilars/follow-on-biologics Revenue by Type (2021-2026) & (USD Million)

Table 61. Europe Biosimilars/follow-on-biologics Revenue by Application (2016-2021) & (USD Million)

Table 62. Europe Biosimilars/follow-on-biologics Revenue by Application (2021-2026) & (USD Million)

Table 63. Europe Biosimilars/follow-on-biologics Revenue by Country (2016-2021) & (USD Million)

Table 64. Europe Biosimilars/follow-on-biologics Revenue by Country (2021-2026) & (USD Million)

Table 65. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Type (2016-2021) & (USD Million)

Table 66. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Type (2021-2026) & (USD Million)

Table 67. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Application (2016-2021) & (USD Million)

Table 68. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Application (2021-2026) & (USD Million)

Table 69. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Region (2016-2021) & (USD Million)

Table 70. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Region (2021-2026) & (USD Million)

Table 71. South America Biosimilars/follow-on-biologics Revenue by Type (2016-2021) & (USD Million)

Table 72. South America Biosimilars/follow-on-biologics Revenue by Type (2021-2026) & (USD Million)

Table 73. South America Biosimilars/follow-on-biologics Revenue by Application (2016-2021) & (USD Million)

Table 74. South America Biosimilars/follow-on-biologics Revenue by Application (2021-2026) & (USD Million)

Table 75. South America Biosimilars/follow-on-biologics Revenue by Country (2016-2021) & (USD Million)

Table 76. South America Biosimilars/follow-on-biologics Revenue by Country (2021-2026) & (USD Million)

Table 77. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Type (2016-2021) & (USD Million)

Table 78. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Type (2021-2026) & (USD Million)

Table 79. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Application (2016-2021) & (USD Million)

Table 80. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Application (2021-2026) & (USD Million)

Table 81. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Country (2016-2021) & (USD Million)

Table 82. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Biosimilars/follow-on-biologics Picture

Figure 2. Global Biosimilars/follow-on-biologics Revenue Market Share by Type in 2020

Figure 3. Human growth hormone

Figure 4. Erythropoietin

Figure 5. Monoclonal antibodies

Figure 6. Insulin

Figure 7. Interferon

Figure 8. Granulocyte-Colony Stimulating Factor

Figure 9. Others

Figure 10. Biosimilars/follow-on-biologics Revenue Market Share by Application in 2020

Figure 11. Blood disorders Picture

Figure 12. Oncology diseases Picture

Figure 13. Chronic and autoimmune diseases Picture

Figure 14. Growth hormone deficiencies Picture

Figure 15. Others Picture

Figure 16. Global Biosimilars/follow-on-biologics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 17. Global Biosimilars/follow-on-biologics Revenue and Forecast (2016-2026) & (USD Million)

Figure 18. Global Biosimilars/follow-on-biologics Revenue Market Share by Region (2016-2026)

Figure 19. Global Biosimilars/follow-on-biologics Revenue Market Share by Region in 2020

Figure 20. North America Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Europe Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Asia-Pacific Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. South America Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Biosimilars/follow-on-biologics Market Drivers

Figure 25. Biosimilars/follow-on-biologics Market Restraints

Figure 26. Biosimilars/follow-on-biologics Market Trends

Figure 27. Novartis (Sandoz) Recent Developments and Future Plans

Figure 28. Synthon Pharmaceuticals Recent Developments and Future Plans

Figure 29. Teva Pharmaceutical Industries Recent Developments and Future Plans

Figure 30. LG Life Sciences Recent Developments and Future Plans

Figure 31. Celltrion Biocon Recent Developments and Future Plans

Figure 32. Hospira Recent Developments and Future Plans

Figure 33. Merck Serono (Merck) Recent Developments and Future Plans

Figure 34. Biogen idec Recent Developments and Future Plans

Figure 35. Genentech (Roche) Recent Developments and Future Plans

Figure 37. Global Biosimilars/follow-on-biologics Revenue Share by Players in 2020

Figure 38. Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 39. Global Top 3 Players Biosimilars/follow-on-biologics Revenue Market Share in 2020

Figure 40. Global Top 10 Players Biosimilars/follow-on-biologics Revenue Market Share in 2020

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 42. Global Biosimilars/follow-on-biologics Revenue Share by Type in 2020

Figure 43. Global Biosimilars/follow-on-biologics Market Share Forecast by Type (2021-2026)

Figure 44. Global Biosimilars/follow-on-biologics Revenue Share by Application in 2020

Figure 45. Global Biosimilars/follow-on-biologics Market Share Forecast by Application (2021-2026)

Figure 46. North America Biosimilars/follow-on-biologics Sales Market Share by Type (2016-2026)

Figure 47. North America Biosimilars/follow-on-biologics Sales Market Share by Application (2016-2026)

Figure 48. North America Biosimilars/follow-on-biologics Revenue Market Share by Country (2016-2026)

Figure 49. United States Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Canada Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Mexico Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Europe Biosimilars/follow-on-biologics Sales Market Share by Type (2016-2026)

Figure 53. Europe Biosimilars/follow-on-biologics Sales Market Share by Application (2016-2026)

Figure 54. Europe Biosimilars/follow-on-biologics Revenue Market Share by Country (2016-2026)

Figure 55. Germany Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. France Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. United Kingdom Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Russia Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Italy Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Asia-Pacific Biosimilars/follow-on-biologics Sales Market Share by Type (2016-2026)

Figure 61. Asia-Pacific Biosimilars/follow-on-biologics Sales Market Share by Application (2016-2026)

Figure 62. Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Share by Region (2016-2026)

Figure 63. China Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Japan Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South Korea Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. India Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Southeast Asia Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Australia Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South America Biosimilars/follow-on-biologics Sales Market Share by Type (2016-2026)

Figure 70. South America Biosimilars/follow-on-biologics Sales Market Share by Application (2016-2026)

Figure 71. South America Biosimilars/follow-on-biologics Revenue Market Share by Country (2016-2026)

Figure 72. Brazil Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Argentina Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Middle East and Africa Biosimilars/follow-on-biologics Sales Market Share by Type (2016-2026)

Figure 75. Middle East and Africa Biosimilars/follow-on-biologics Sales Market Share by Application (2016-2026)

Figure 76. Middle East and Africa Biosimilars/follow-on-biologics Revenue Market Share by Country (2016-2026)

Figure 77. Turkey Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Saudi Arabia Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. UAE Biosimilars/follow-on-biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz